DarioHealth Corp. (NASDAQ: DRIO) has announced a new partnership with a prominent U.S. research and medical institution, marking its second major healthcare employer signing. This collaboration, already generating revenue in 2025, underscores DarioHealth's growth and leadership in AI-powered digital health solutions for chronic condition management.

The institution selected DarioHealth for its proven impact, personalization, and seamless integration, aiming to provide employees with comprehensive, data-driven support. Dario's platform includes Dario Health, Dario Mind, and Dario Move, addressing multiple chronic conditions such as diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Steven Nelson, Chief Commercial Officer of DarioHealth, emphasized the increasing demand for solutions that deliver real-world results. He noted that leading organizations are shifting from generic wellness apps to data-driven platforms that demonstrate clinical, financial, and cultural ROI. The partnership validates Dario's ease of deployment and its ability to meet the performance standards of demanding enterprise workforces.

The new employer, a nationally strategic institution, is committed to offering employees a personalized health journey supported by AI, real-time data, and integrated coaching through a single platform. DarioHealth's engagement rates are reportedly above industry averages, with early outcomes showing significant reductions in A1c, blood pressure, and MSK-related pain, along with improvements in mental well-being.

DarioHealth believes that partnerships with leading healthcare systems are crucial for establishing trust and reliability in the digital health sector. The company's platform provides personalized interventions driven by data analytics and one-on-one coaching for various chronic conditions. Dario's solutions are available globally to health plans, self-insured employers, providers, and consumers.

DarioHealth Corp. is a digital health company focused on revolutionizing chronic condition management through a user-centric platform. The company's solutions deliver personalized and dynamic interventions for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. For more information, visit http://dariohealth.com.

Forward-Looking Statements: This announcement contains forward-looking statements regarding expectations of recurring revenue in 2025, the capabilities of Dario's AI-driven platform, the shift towards data-driven platforms, and the impact of partnerships with healthcare systems. These statements are subject to risks and uncertainties, including regulatory approvals, product demand, market acceptance, competitive factors, and the adequacy of cash resources. Actual results may differ materially from those projected. The company undertakes no obligation to update these statements except as required by law.